Treatment of Reflux Esophagitis with Blockers, Antacids and Prokinetic Drugs:An Analysis of Randomized Clinical Trials

References

• Ismail-Beigi F, Horton P F, Pope C E, II. Histological consequences of gastroesophageal ri'flux in man. Gastroenterology 1970; 58: 103–174
   Google Scholar
• Seefeld I I, Krejs G I, Siebcmnaim R E, Blum A L. Esophageal histology in gastroesophageal reflux. Morphonielrie findings in suction biopsies. Am J Dig Dis 1977; 22: 956–964
   PubMedGoogle Scholar
• Sheüle A, Brändli H, Pelloni S, Koelz H R, Pirozynski W J, Blum A L. Endoskopische Diagnose der Ösophagitis. Wo liegt die Grenze zum Normal^← Dtseh Med W'schr 1977; 102: 606–609
   PubMedGoogle Scholar
• Wesdorp E, Bartelsmait J, Pape K, Dekker W, Tylgat G N. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978; 74: 821–824
   PubMed Web of Science ®Google Scholar
• Powell-Jackson P., Barkley H, Norlhfield T C. Effect of cimetidine in symptomatic gaslro-oesophageal reflux. Lancet 1978; 2: 1068–1069
   PubMed Web of Science ®Google Scholar
• Lepsien C, Honnenberg A, Beiges W, Weber K B, Wienbeck M, Siewert I B, Blum A L. Die Bchuiid-lurig der Refluxösophagilis mit Gimelidin. Dtseh Med Wsr. hr 1979; 901–906
   Google Scholar
• Fiasse R, Hanin G., Lepot A, Deschamps C, Lanty F, Dive G. Controlled trial of cimetidine in reflux esophagitis. Dig Dis Sei 1980; 25: 750–755
   Google Scholar
• Festen H PM, Driessen W MM, Lamers C BH, Van Tongeren J HM. Cimetidine in the treatment of seven' ulcerative reflux oesophagitis. Results of an 8-week double-blind study and of subsequent long-term maintenance treatment. Nelh J Med 1980; 23: 237–240
   PubMed Web of Science ®Google Scholar
• Bradby G VH, Hawkins C F, Moure A M. Cimetidine (Tagamet) in oesophageal reflux. Clin Trials. I 1980; 17: 81–83
   Google Scholar
• Druguel M, Lambert R. Oral cimetidine in reflux-oesophagitis: a double-blind controlled trial. Cimetidine, Proreedings of the Second National Symposium, A Dresse, F. C Barbier Harvengt, G N Tylgat. Exeerpta Mediea, Amsterdam 1980; 30–38
   Google Scholar
• Greaney M G, Irvin T T. Cimetidine lor the treatment of symptomatic gastro-oesophageal reflux. Br J Clin Pracl 1981; 35: 21–24
   PubMedGoogle Scholar
• Behar J, Brand D L, Brown F C, Castell I X, Cohen H, Crossley R J, Pope C E, II, Winans C S. Cimetidine in the trealinent of symptomatic gastroesophageal reflux. Gastroenterology 1978; 74: 441–448
   PubMed Web of Science ®Google Scholar
• Brighl-Asare P, El-Bassoussi M. Cimetidine. inetoclopranu'de, or placebo in the treatment of symptomatic gastroesophageal reflux. J Clin Gastroenterol 1980; 2: 149–156
   PubMedGoogle Scholar
• Furman D, Mensh B, Winau C., Marignani P, McKinley M, DuBovik S, MoCallum R W. A doubli'-blind trial comparing high dose liquid antacid to placebo and cimetidine in improving symptoms and objective parameters in gastroesophageal reflux. Gastroenterology 1982; 82: 1062, abstract
   Web of Science ®Google Scholar
• Brown P. Cimetidine in the treatment of reflux esophagitis. Med J Aust 1979; 2: 90–97
   Google Scholar
• Breen K J, Desmond P Y, Whelan G. Treatment of reflux oesophagitis. A randomized, controlled evaluation of ciinetidine. Med J Aust 1983; 2: 555–558
   PubMed Web of Science ®Google Scholar
• Dawson J., Barnard J, Delattre M. Ciinetidine 800 mg at bedtime in refluxoesophagitis: a multicentre trial. Diseases of the Esophagus, J R Siewert, A H Holscher. Springer-Verlag, Berlin 1988, in press
   Google Scholar
• Kaul B, Petersen H, Erichsen H, Myrvold H E, Grette K, Halvorsen T, Fjosne U. Gastroesophageal reflux disease. Acute and maintenance treatments with ciinetidine. Scand J Gastroenterol 1986; 21: 139–145
   PubMed Web of Science ®Google Scholar
• Archambaull A P, Farley A, Clealor I G, Hershfield N B, Naverl H, Prokipchuk E J, Thomson A B. Ciinetidine therapy for gastroesophageal reflux disease. West J Med 1985; 143: 616–621
   PubMedGoogle Scholar
• Berslad A. Overview of ranitidine hi refluxoesophagitis: its effect on symptoms, endoscopic appearance and histology. The clinical use of ranitidine. The second international symposium on ranitidine, J J Misiewicz, K J Wonnsley. Medicine Publishing Foundation, Oxford 1982; 297–304
   Google Scholar
• Gem A E, Gough K R, Hellier M D, Walker J M. Ranitidine for refluxoesophagitis: an interim report of a double-blind controlled trial. Scand J Gastroenterol 1982; 17(suppl 78)237, abstract
   Google Scholar
• Coy J A, Mayuard J H, McNaughtou W M, O'Shea A. Ranitidine and placebo in the treatment of reflux oesophagitis. A double blind randomized trial. Med J Aust 1983; 2: 558–561
   PubMedGoogle Scholar
• Sherbaniuk R W, Wensel R, Trautman A, Grace M, Lentle B, Walker K, Salkie M, Tomson A BR. Gastrin, gastric emptying, and gastroesophageal reflux after ranitidine. J Clin Gastroenterol 1983; 5: 239–244
   PubMed Web of Science ®Google Scholar
• Wesdorp I CE, Dekker W, Klinkenberg-Knol E C. Treatment of reflux oesophagitis with ranitidine. Gut 1984; 24: 921–924
   Google Scholar
• Hine K R, Holmes G K, Melikian V, Lucey M, Fairclough P D. Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study. Digestion 1984; 29: 119–123
   PubMed Web of Science ®Google Scholar
• Nelis G F. Ranitidine in the management of gastro-oesophageal reflux disease. Neth J Med 1985; 28: 197–200
   PubMedGoogle Scholar
• Grove O, Bekker C, Jeppe-Hansen M G, Karstoft E, Sanchez G, Axelsson C K, Nielsen H O, Andersen Rask-Madsen B. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial. J. Scand J Gastroenterol 1985; 20: 457–461
   PubMed Web of Science ®Google Scholar
• Lehtola J, Niemela S, Martikainen J, Krekela I. Ranitidine, 150 nig three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study. Scand J Gastroenterol 1986; 21: 175–180
   PubMed Web of Science ®Google Scholar
• Johansson K E, Boeryd B, Johansson K, Tibbling L. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 769–778
   PubMed Web of Science ®Google Scholar
• Gustavsson S, Bergström R, Erwall C, Krog M, Lindholm C E, Nyren O. Reflux esophagitis: assessment of therapy effects and observer variation by video documentation of endoscopy findings. Scand J Gastroenterol 1987; 22: 585–591
   PubMed Web of Science ®Google Scholar
• Sontag S, Robinson M, McCallum R W, Barwick K W, Nardi R. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Arch Intern Med 1987; 147: 1485–1491
   PubMedGoogle Scholar
• Harvey R F, Gordon P C, Hadley N, Long D E, Gill T R, Macpherson R I, Beats B C, Tottle A J. Effects of sleeping with the bed-head raised and of ranitidine hi patients with severe peptic oesophagitis. Lancet 1987; 2: 1200–1203
   PubMed Web of Science ®Google Scholar
• Rohner H G, Wienbeck M. RAN 2–1-Studiengrup-pe Zwei oder erne Tagesdosis Ranitidin zur Be-handlung der Refluxösophagitis?. Z Gastroenterol 1986; 396–402
   PubMedGoogle Scholar
• Bovero E, Cheli R, Barbara L, Baldi F, Boero A, Mura G C, Camarri E, et al. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte italian multicentre study. Hepato-Gastroen-terol 1987; 34: 155–159
   PubMedGoogle Scholar
• Schaub N, Thomas J M, Misiewicz J J, Lovell D, Trotman I F. Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease. Hepato-Gastroenterol 1986; 33: 208–213
   PubMedGoogle Scholar
• Pace F, Lazzaroni M, Sangaletti O, Baroni S, Porro G B. Gastroesophageal reflux before and after healing of peptic oesophagitis. Ital J Gastroenterol 1986; 18: 48–49
   Google Scholar
• Fielding J F, Doyle G D. Comparison between ranitidine and ciinetidine in the treatment of reflux oesophagitis. Ir Med J 1984; 77: 356–357
   PubMedGoogle Scholar
• Kimmig J M. Cinietidin und Ranitidin in der Be-handlung der Refluxoesophagitis. Z Gastroenterol 1984; 22: 373–378
   PubMed Web of Science ®Google Scholar
• Noya G, Dettori G, Muscas A, Spirito R, Niolu P, Marongiu G, Biglioli P. Cimetidina versus ranitidine nel trattamento dell'esofagite peptica. Min. Med 1983; 74: 787–790
   Google Scholar
• Gonzalez J C, Da Silva N, Diaz D, Casalta V, Betancourt C, Guirola E, Pillkhan J, et al. Ciinetidine vs. ranitidine in the treatment of refluxoesophagitis. Dig Dis Sci 1986; 31: 467, abstract
   Google Scholar
• Wienbeck M, Rohner H G, Huttemann W, Pelz W. Etintidin versus Ranitidin in der Behandlung der Refluxösophagitis. Dtsch Med Wschr 1986; 111: 1501–1502
   PubMedGoogle Scholar
• Siewert J R, Ottenjann R, Heihnami K, Neiss A, Döpfer H. Therapie und Prophylaxe der Refluxösophagitis. Z Gastroenterol 1986; 24: 381–395
   PubMedGoogle Scholar
• Ferguson R, Dronfield M W, Atkinson M. Cimetidine in treatment of reflux oesophagitis with peptic stricture. Br Med J 1979; 2: 472–474
   PubMed Web of Science ®Google Scholar
• Thor K. Treatment of reflux esophagitis with cimetidine in a liquid suspension (letter). J Clin Gastroenterol 1987; 9: 116–117
   PubMedGoogle Scholar
• Sekiguchi T, Nishioka T, Kogure M, Kusano M, Horikoshi T, Sugiyama Kobayashi T. Once-daily administration of famotidine for reflux esophagitis. S. Scand J Gastroenterol 1987; 22(suppl 134)51–54
   Google Scholar
• v.d. Hameeteman W, Boomgaard D M, Dekker W, Schrijver M, Wesdorp I CE, Tytgat G NJ. Sucralfate versus cimetidine in reflux esophagitis. A single-blind multicenter study. J Clin Gastroenterol 1987; 4: 390–394
   Google Scholar
• Petrokubi R J, Jeffries G H. Cimetidine versus antacid in scleroderma with reflux esophagitis. Gastroenterology 1979; 77: 691–695
   PubMed Web of Science ®Google Scholar
• Thanik K D, Chevy W Y, Shah A N, Hamilton D L, Nadelson N W. Comparative studies on effects of cimetidine and bethanechol in the treatment of reflux esophagitis. Gastroenterology 1980; 78: 1277, abstract
   Google Scholar
• Simon B, Mueller P. Comparison of the effect of sucralfate and ranitidine in reflux esophagitis. Am J Med 1987; 83(Suppl. 3B)43–47
   PubMed Web of Science ®Google Scholar
• Guslandi M, Testoni P A, Passaretti S, Masci E, Ballarin E, Comin U, Marchi R, et al. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis. Hepato-Gastroenterol 1983; 30: 96–1988
   PubMed Web of Science ®Google Scholar
• Tönnesen H, Andersen J R, Christoffersen P, Kaas-Claesson N. Reflux oesophagitis in heavy drinkers. Effect of ranitidine and alginate/metoclopramide. Digestion 1987; 38: 69–73
   PubMed Web of Science ®Google Scholar
• Masci E, Testoni P A, Passaretti S, Guslandi M, Tittobello A. Comparison of ranitidine, dom-peridone maleate and ranitidine 4- domperidone maleate in the short-term treatment of reflux oesophagitis. Drugs Exptl Clin Res 1985; 11: 687–692
   PubMedGoogle Scholar
• Janisch H D, The CISRAN-Srudy-Group. A double-blind multicenter trial to compare the efficacy of cisapride (CIS) and ranitidine (RAN) in the acute treatment of gastroesophageal reflux disease (GERD). Gastroenterology 1986; 90: 1475, abstract
   Google Scholar
• Dammann H G, Blum A L, Lux G, Rehner M, Riecken E O, Schiessel R, Wienbeck M, et al. Un-terschiedliche Heilungstendenz der Reflux-osophagitis naeh Omeprazol und Ranitidin. Ergebnisse einer deutsch-österreichisch-schweizerischen Multizenterstudie. Dtsch Med Wsehr 1986; 111: 123–128
   PubMedGoogle Scholar
• Klinkenberg-Knol E C, Jansen J M, Festen H P, Meuwissen S G, Lamers C B. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 1: 349–351
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Coenegrachts J L, Rutgeerts L, Schurmans P. Omeprazole (40 mg) is superior to ranitidine in the short term treatment of ulcerative reflux esophagitis. Gastroenterology 1987; 92: 1681, abstract
   Web of Science ®Google Scholar
• Lundell L, Fansa O, Sandmark S. Omeprazole or ranitidine in the treatment of refluxoesophagitis – result from a double-blind randomized Scandinavian multicentre study. Gut 1987; 28: A 1375, abstract
   Google Scholar
• Havelund T, Laursen L S, Skoubo-Kristensen E, Andersen B N, Pedersen S A, Jensen K B, Fenger C, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J 1988; 296: 89–92
   PubMed Web of Science ®Google Scholar
• Galmiche J P, Brandstatter G, Kerstan E, Reichel W, Schuetze K, Yitaux J, Yogten A J. Double-blind placebo-controlled study of cisapride as add on therapy in patients treated with cimetidine for refluxoesophagitis, to be published
   Google Scholar
• Temple J G, Bradby G Y, O'Connor F, Panesar K S, Mulligan T O, Robinson T J, Ward D W. Cimetidine and metoclopramide in oesophageal reflux disease. Br Med J 1983; 286: 1863–1864
   PubMed Web of Science ®Google Scholar
• Liebermann D A, Keeffe E B. Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med 1986; 104: 21–26
   PubMed Web of Science ®Google Scholar
• Borkent M V, Beker J A. Treatment of ulcerative reflux oesophagitis wilth colloidal bismuth subci-trate in combination with cimetidine. Gut 1988; 29: 385–389
   PubMed Web of Science ®Google Scholar
• Wienbeck M, The RANPRIDE Study Group. Does a motor stimulating agent improve the therapeutic effect of H2-blockers in reflux esophagitis?. Gastroenterology 1986; 90: 1691, abstract
   Google Scholar
• Koelz H R, Birchler R, Bretholz A, Bron B, Capitaine Y, Delmore G, Fehr H F, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–1205
   PubMed Web of Science ®Google Scholar
• Johansson K E, Tibbling L. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment. Scand J Gastroenterol 1986; 21: 487–492
   PubMed Web of Science ®Google Scholar
• Koop H, Bauer A, Klein M, Arnold R. Yerminderte Sauresuppression unter Ranitidin bei Patienten mit schwerer Refluxosophagitis. Z Gastroenterol 1987; 25: 503, abstract
   Google Scholar
• Robertson D AF, Aldersley M A, Shepherd H, Lloyd R S, Smith C L. H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?. Gut 1987; 28: 946–949
   PubMed Web of Science ®Google Scholar
• Robinson M G, Orr W C, McCallum R, Nardi R. Do endoscopic findings influence response to H2 antagonist therapy for gastroesophageal reflux disease?. Am. J Gastroenterol 1987; 82: 519–522
   PubMed Web of Science ®Google Scholar
• Berenson M M, Sontag S, Robinson M G, McCallum R M. Effect of smoking in a controlled study of ranitidine treatment in gastroesophageal reflux disease. J Clin Gastroenterol 1987; 9: 499–503
   PubMed Web of Science ®Google Scholar
• Hetzel D J, Dent J, Reed W, Narievala F, Mackin-Non M, Laurence B. Healing and relapse of reflux -oesophagitis after treatment with omeprazole 20 mg or 40 mg daily. Gut 1987; 28: 1376–1377
   Google Scholar
• Fausa O, Aadland E, Lotveit T. Omeprazole in the treatment of patients with severe erosive oesophagitis resistent to treatment with H2-recep-tor antagonists. Scand J Gastroenterol 1987; 22(suppl. 135)38, abstract
   Google Scholar
• Bardhan K D, Morris P, Thompson M, Dhande D, Hinchliffe R K, Daly M J, Carol N, Krakowczyk C. Omeprazole in the treatment of erosive esophagitis (EE) refractory to high-dose cimetidine. Gastroenterology 1987; 92: 1306, abstract
   Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Meuwissen S GM. Is omeprazole effective in the treatment of patients with reflux esophagitis not responding to Ffe-receptor antagonists?. Gastroenterology 1987; 92: 1472, abstract
   Web of Science ®Google Scholar
• Bright-Asare P, Behar J, Brand D L, Brown F C, Gasteil D O, Cohen S, Debas H, et al. Effects of long term maintenance cimetidine (CIM) therapy on gastroesophageal reflux disease (GERD). Gastroenterology 1981; 82: 1025, abstract
   Google Scholar
• McCallum R W, Sontag S J, Vlahcevic Z R, Robinson M G, Orr W C, Zimmerman T W, Behar J, et al. Ranitidine vs. placebo in long-term treatment of gastroesophageal reflux (GERD). Am J Gastroenterol 1985; 80: 864, abstract
   Google Scholar
• Graham D Y, Smith J L, Patterson D J. Why do apparently healthy people use antacid tablets?. Am J Gastroenterol 1983; 78: 257–260
   PubMed Web of Science ®Google Scholar
• Meyer C, Berenzweig H, Kuljian B, Callachan C, McCallum R W. Controlled trial of antacid (AA) versus placebo (P) on relief of heartburn. Gastroenterology 1979; 76: 1201, abstract
   Web of Science ®Google Scholar
• Laitinen S, Stahlberg M, Kairaluoma M I, Kiviniemi H, Paakonen M, Lahtinen J, Poikolainen E, Aukee S. Sucralfate and alginate/ antacid in reflux esophagitis. Scand J Gastroenterol 1985; 20: 229–232
   PubMed Web of Science ®Google Scholar
• Beeley M, Warner J O. Medical treatment, of symptomatic hiatus hernia with low-density compounds. CUIT Med Res Opin 1972; 1: 63–69
   PubMedGoogle Scholar
• Stanciu C, Bennett J R. Alginate/antacid in the reduction of gastro-cesophageal reflux. Lancet 1974; 1: 109–111
   PubMed Web of Science ®Google Scholar
• Barnardo D E, Lancaster-Smith M, Strickland I D, Wright J T. A double-blind controlled trial of ‘Gaviscon’ in patients with symptomatic gastroesophageal reflux. Curr Med Res Opin 1975; 3: 388–391
   PubMedGoogle Scholar
• Scobie B A. Endoscopically controlled trial of alginate and antacid in reflux oesophagitis. Med J Aust 1976; 1: 627–628
   PubMed Web of Science ®Google Scholar
• McHardy G. A multicentric, randomized clinical trial of gaviscon in reflux esophagitis. South Med J 1978; 71(Suppl 1)16–21
   PubMedGoogle Scholar
• Chevrel B. A comparative crossover study on the treatment of heardsurn and epigastric pain: liquid gaviscon and a magnesium-aluminium antacid gel. J lnt Med Res 1980; 8: 300–303
   Google Scholar
• Graham D Y, Patterson D J. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci 1983; 28: 559–565
   PubMed Web of Science ®Google Scholar
• Reed P I, Davies W A. Controlled trial of a new-dosage form of carbenoxolone (pyrogastrone) in the treatment of reflux esophagitis. Dig Dis Sci 1978; 23: 161–165
   Google Scholar
• Young G P, Nagy G S, Myren J, Kronborg I J, Logan K R, Reed P I, Hopper J L. Treatment of reflux oesophagitis with a carbenoxolone/antacid/algi-nate preparation. A double-blind controlled trial. Scand J Gastroenterol 1986; 21: 1098–1104
   PubMed Web of Science ®Google Scholar
• Ogilvie A L, Atkinson M. Does dimethicone increase the efficacy of antacids in the treatment of reflux oesophagitis?. J Roy Soc Med 1986; 79: 584–587
   PubMed Web of Science ®Google Scholar
• Venables C W, Bell D, Eccleston D. A double blind study of metoclopramide in symptomatic peptic oesophagitis. Postgrad Med J 1973; 49: 73–77
   PubMedGoogle Scholar
• Paull A, Kergrant A. A controlled trial of metoclopramide in reflux oesophagitis. Med J Aust 1974; 2: 627–629
   PubMedGoogle Scholar
• McCallum R W, Ippolitti A F, Cooney C, Sturde-Vant R AL. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. N Engl J Med 1977; 296: 354–357
   PubMed Web of Science ®Google Scholar
• McCallum R W, Fink S M, Winnan G R, Avella J, Callachan C. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. Am J Gastroenterol 1984; 79: 165–172
   PubMed Web of Science ®Google Scholar
• Guslandi M, Testoni P A, Passaretti S, Masci E, Ballarin E, Comin U, Marchi R, et al. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis. Hepato-Gastroenterol 1983; 30: 96–98
   PubMed Web of Science ®Google Scholar
• Goethals C. Doniperidone in the treatment of post-prandial symptoms suggestive of gastroesophageal reflux. Curr Ther Res 1979; 26: 874–880
   Web of Science ®Google Scholar
• Valenzuela J E. Effect of domperidone on the symptoms of refluxoesophagitis. International Congress and Symposium. Royal Society of Medicine. 1981; 51–56, series No. 36
   Google Scholar
• Blackwell J N, Heading R C, Fettes M R. Effect of domperidone in lower esophageal sphincter pressure and gastroesophageal reflux in patients with peptic oesophagitis. International Congress and Symposium. Royal Society of Medicine. 1981; 57–65, series No. 36
   Google Scholar
• Farrell R L, Roling G T, Castell D O. Cholinergic therapy of chronic heartburn. A controlled trial. Ann Intern Med 1974; 80: 573–576
   PubMed Web of Science ®Google Scholar
• Thanik K D, Chey W Y, Shah A N, Gutierrez J G. Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings. Ann Intern Med 1980; 93: 805–808
   PubMed Web of Science ®Google Scholar
• Saco L S, Orlando R C, Levinson S L, Bozymski E M, Jones J D, Frakes J T. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis. Gastroenterology 1982; 82: 1369–1373
   PubMed Web of Science ®Google Scholar
• Lepoutre L, Vanderlinden I, BoUen G, Vandewalle N, Cabooter M, Laukens P, Reytjens A, Yerlinden M. Controlled study of cisapride in the treatment of grade II and III oesophagitis. Gastroenterology 1987; 92: 1501, abstract
   Google Scholar
• Nicolaidis C L, Kehagioglou K, Mautzaris G, Papadatou-Marinou A, Saklaridis J, Georgiotis D, Michailidis D. Therapeutic effect of two dosages of cisapride in controlling chronic reflux symptoms in esophagitis patients. Curr Ther Res Clin Exptl 1987; 42: 1059–1065
   Google Scholar
• Botha J J, Grundling H K. Healing of moderate to severe oesophagitis. A double-blind placebo-controlled trial of cisapride, to be published
   Google Scholar
• Case W G, Williams N S. Cisapride in the treatment of chronic symptomatic refluxoesophagitis: a double-blind controlled trial, to be published
   Google Scholar
• Manousos O N, Manidis A, Michailidis D. Treatment of reflux symptoms in esophagitis patients: comparative trial of cisapride and metoclop-ramide. Curr Ther Res Clin Exptl 1987; 42: 807–813
   Web of Science ®Google Scholar
• Arabehety J T, Leitao O, Manousos O N, Serrano C, Fassler S, Olarte M. Cisapride in gastroesophageal reflux: a double-blind comparison of 2 dosage regimens with metoclopramide, to be published
   Google Scholar